ALX Oncology Holdings, Inc. (ALXO)
1.47
+0.03
(+2.08%)
USD |
NASDAQ |
Dec 09, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Shareholders Equity (Quarterly): 44.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Prelude Therapeutics, Inc. | 58.53M |
| Werewolf Therapeutics, Inc. | 29.61M |
| Erasca, Inc. | 347.89M |
| Immuneering Corp. | 227.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.72M |
| Total Liabilities (Quarterly) | 37.92M |
| Debt to Equity Ratio | 0.3484 |
| Current Ratio | 2.399 |
| Net Debt Paydown Yield | 0.38% |